The Role of Parafibromin, Galectin-3, HBME-1, 
and Ki-67 in the Differential Diagnosis of Parathyroid Tumors.

Giant parathyroid adenoma: differential aspects compared to parathyroid carcinoma. Endocrinol Diabetes Metab Case Rep (2017) 0.79

Clinical review 122: Parathyroid carcinoma. J Clin Endocrinol Metab (2001) 5.04

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07

Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med (2003) 3.07

The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol (2005) 2.58

Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res (2004) 1.47

Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis. Diagn Pathol (2012) 1.36

Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J Surg Pathol (1993) 1.25

Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification. Endocr Relat Cancer (2007) 1.20

Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res (1998) 1.18

Parathyroid carcinoma: sixteen new cases and suggestions for correct management. World J Surg (1998) 1.08

Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr Relat Cancer (2006) 1.08

Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. Virchows Arch (2007) 1.05

Defining a molecular phenotype for benign and malignant parathyroid tumors. Cancer (2009) 1.05

Functioning parathyroid carcinoma: clinicopathologic features and rational treatment. Semin Surg Oncol (1997) 1.05

Parathyroid carcinoma. J Surg Oncol (2005) 1.04

Parafibromin expression is an independent prognostic factor for colorectal carcinomas. Hum Pathol (2011) 0.98

Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases. Hum Pathol (2005) 0.97

Immunohistochemical Analysis of the Cell Cycle-Associated Antigens Ki-67 and Retinoblastoma Protein in Parathyroid Carcinomas and Adenomas. Endocr Pathol (1995) 0.91

Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma. J Pathol (2004) 0.91

Galectin-3 and Ki-67 expression in multiglandular parathyroid lesions. Am J Clin Pathol (2006) 0.90

Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas. Ann Surg Oncol (2013) 0.88

Parafibromin expression in lung normal tissue and carcinoma: its comparison with clinicopathological parameters of carcinoma. Histol Histopathol (2011) 0.88

Immunhistochemical expression of galectin-3 in cancer: a review of the literature. Turk Patoloji Derg (2012) 0.87

Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer. World J Surg (2014) 0.82

Parathyroid Carcinoma: Diagnosis and Clinical Implications. Turk Patoloji Derg (2015) 0.79

Pathology of parathyroid tumors. Semin Surg Oncol (1997) 0.78